SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases

The purpose of this manuscript is to review the effects of sodium-glucose cotransport protein 2 inhibitors (SGLT2is) in patients with chronic kidney disease according to basic mechanisms, current recommendations, and future perspectives. Based on growing evidence from randomized, controlled trials,...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Costanzo, Assunta, Esposito, Giovanni, Indolfi, Ciro, Spaccarotella, Carmen Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218404/
https://www.ncbi.nlm.nih.gov/pubmed/37240080
http://dx.doi.org/10.3390/ijms24108732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218404/
https://www.ncbi.nlm.nih.gov/pubmed/37240080
http://dx.doi.org/10.3390/ijms24108732

Ejemplares similares